Harmony Biosciences HoldingsHarmony Biosciences Holdings
Harmony Biosciences Holdings

Harmony Biosciences Holdings

Biopharmaceutical company focused on developing and commercializing innovative treatments for rare neurological disorders.

Website
2017Active332
Rate
Advertise here

About

Harmony Biosciences Holdings is a biopharmaceutical company dedicated to addressing unmet medical needs in rare neurological diseases. Their primary focus is on developing and commercializing therapies for conditions such as narcolepsy. They aim to improve the lives of patients by providing novel treatment options.

Technology stack

detected 2026-06-22
Est. monthly stack spend~$1,490/mo
CDN
Cloudflare
EmailMimecast
gateway-fronted
Stack
WordPress
Analytics
Google Tag Manager
SEO
Yoast SEO
Video
Vimeo
Comments

No comments yet. Be the first to share your take.

Frequently asked

What does Harmony Biosciences Holdings do?

Harmony Biosciences Holdings is a biopharmaceutical company dedicated to addressing unmet medical needs in rare neurological diseases. Their primary focus is on developing and commercializing therapies for conditions such as narcolepsy. They aim to improve the lives of patients by providing novel treatment options.

How much funding has Harmony Biosciences Holdings raised?

Harmony Biosciences Holdings has raised a total of $401M in funding. The most recent round on record is IPO.

Where is Harmony Biosciences Holdings headquartered?

Harmony Biosciences Holdings is headquartered in Plymouth Meeting, United States.

When was Harmony Biosciences Holdings founded?

Harmony Biosciences Holdings was founded in 2017.

What industry does Harmony Biosciences Holdings operate in?

Harmony Biosciences Holdings operates in Biotech, MedTech, HealthTech, Drug Discovery, Clinical Trials, Neurology.

How many employees does Harmony Biosciences Holdings have?

Harmony Biosciences Holdings has approximately 332 people on record.